The healthcare communications and public relations group.
14-Dec-2017 – 81.75p – £269.9m – PER 13.3
Trading Update For The 11 Months To End November 2017 – Growth has been strong and expects to “reach at least market consensus”, which is £22.8m PBT. Net Debt is up, it seems from about £30m last time to about £45m now. Outlook is confident.
Doubled in 2018 this still looks reasonable attractive but probably priced about right. Will keep an eye on updates.
6-Mar-2018 – 77.6p – £256.2m – PER 12.6
Preliminary Results For The 12 Months To End December 2017 – Revenue up 9% at £197.0m (2016: £180.1m), PBT up 52% at £24.4m (2016: £16.0m), Diluted EPS 5.8p (2016: 4.0p) and the Total Dividend for the year will be 2.0p (2016: 1.75p). Net Debt is up from £31.6m to £36.3m. CEO – “Despite increasing FX headwinds, the year has started well with good trading momentum and Huntsworth is well positioned for further growth in 2018″.
Doubled in 2018 it looks like it has the potential to keep going. Considering an initial investment here, if not it will go on my Watchlist, 75p.
24-May-2018 – 99p – £326.9m – PER 14.7
I am Long here and will remain so for now.
24-Jul-2018 – 132.5p – £438.9m – PER 18.1
Interim Results For The 6 Months To End June 2018 – Revenue up 8% to £102.2m with PBT up 9% to £11m, EPS is up 11% and the Interim Dividend is up 27%.
I am Long here and would have liked to have seen a little more progress than this. Quite wary that of this statement “Board remains confident in the full year outcome” as it does not mention expectations at all. The Dividend increase seems like a sweetener here and although I am Long I will keep a close eye on the market reaction here this morning and the days ahead.
12-Dec-2018 – 97p – £339.1m – PER 11.9
Trading Update For The 11 Months To End November 2018 – On target for PBT to be at least in-line (£29.4m), expecting continued good growth across all of its businesses into 2019.
I sold out here in July as the Interim Results seemed a little too cautious. I may well revisit as this doesn’t sound as bad at all – I’ll keep an eye out for Broker notes.
5-Mar-2019 – 96p – £335m – PER 11.8
Preliminary Results For The 12 Months To End December 2018 – Revenue up 14% (1.4% LFL), PBT up 15% (ahead of expectations), EPS up 24% and the FY Dividend is up 15%.
I sold out here a while ago as the Interim Results seemed a little cautious. I may well revisit as these results look pretty good – Will keep an eye out for updated Broker notes.
9-May-2019 – 94p – £325m – PER 10.8
Trading Update For The 4 Months To End April 2019 – In-line with Net Debt lower than expected.
Based on forecasts this looks fairly valued here to me.
23-Jul-2019 – 93p – £343m – PER 9.8
Interim Results For The 6 Months To End June 2019 – Expecting a strong H2 to meet FY expectations.
Looks like there’s value here on the assumption that H2 is strong so it’s a case of waiting to see the actuals. Based on the latest Broker note this morning, in my opinion, this looks way undervalued on a 1 Year view and about fairly valued on a 2 year view – Considering the Net Debt would like to see a 10% upgrade to 2020E EPS to make this more attractive.